logo
Daylight can boost the immune system's ability to fight infections

Daylight can boost the immune system's ability to fight infections

RNZ News25-05-2025
By Chris Hall * of
How does the immune system know when it's daytime? File photo.
Photo:
Unsplash
Ever found yourself out of sync with normal sleep patterns after late nights or working a night shift? It could be you're experiencing what scientists call social jet lag.
The term describes the misalignment between our internal body clock (circadian rhythm) and our social schedule.
Social jet lag associated with irregular sleep patterns and inconsistent exposure to daylight is increasingly common, and has been linked with a weakened immune system.
Disruption of our circadian rhythms through shift work, for example, has been shown to have a negative impact on our ability to fight infections.
These observations reinforce the idea that maintaining a robust circadian rhythm through regular exposure to daylight supports a healthy immune system.
But how does the immune system know when it's daytime? That is precisely what our research, published today in Science Immunology, has uncovered. Our findings could eventually deliver benefits for the treatment of inflammatory conditions.
Circadian rhythms are a fundamental feature of all life on Earth. Believed to have evolved some 2.5 billion years ago, they enable organisms to adapt to challenges associated with the 24-hour solar day.
At the molecular level, these circadian rhythms are orchestrated through a genetically encoded multi-component time keeper called a circadian clock. Almost all cells are known to have the components for a circadian clock. But how they function within different cell types to regulate their behaviour is very poorly understood.
In the laboratory, we use zebrafish - small freshwater fish commonly sold in pet stores - as a model organism to understand our immune response to bacterial infection.
We use larval zebrafish because their genetic makeup and immune system are similar to ours. Also, they have transparent bodies, making it easy to observe biological processes under the microscope.
Chris Hall (left) and co-researcher Guy Warman with the zebrafish used as a model organism in their study.
Photo:
Supplied / Chris Hall
We focus on an immune cell called a "neutrophil", a type of white blood cell. We're interested in these cells because they specialise in killing bacteria, are first responders to infection, and are the most abundant immune cell in our bodies.
Because they are very short-lived cells, neutrophils isolated from human blood are notoriously difficult to work with experimentally. However, with transparent larval zebrafish, we can film them to directly observe how these cells function, within a completely intact animal.
Our initial studies showed the strength of immune response to bacterial infection peaked during the day, when the animals are active.
We think this represents an evolutionary response that provides both humans and zebrafish a survival advantage. Because diurnal animals such as humans and zebrafish are most active during daylight hours, they are more likely to encounter bacterial infections.
This work made us curious to know how this enhanced immune response was being synchronised with daylight. By making movies of neutrophils killing bacteria at different times of the day, we discovered they killed bacteria more efficiently during the daytime than at night.
We then genetically edited neutrophils to turn off their circadian clocks by carefully removing specific clock components. This is an approach similar to removing important cogs from an analogue clock so it doesn't tick anymore.
This led to the discovery that these important immune cells possess an internal light-regulated circadian clock that alerts the cells to daytime (similar to an alarm clock). This boosts their ability to kill bacteria.
Our next challenge is to understand exactly how light is detected by neutrophils, and whether human neutrophils also rely on this internal timing mechanism to regulate their antibacterial activity.
We're also curious to see if this killing mechanism is restricted to certain types of bacteria, such as those we're more likely to encounter during the day. Or is it a more general response to all infectious threats (including viral infections)?
This research unlocks the potential for developing drugs that target the neutrophil circadian clock to regulate the cells' activity. Given neutrophils are the first and most abundant immune cells to be recruited to sites of inflammation, the discovery has very broad implications for many inflammatory conditions.
* The research described here was led by PhD candidates Lucia Du and Pramuk Keerthisinghe, and was a collaboration between the Hall laboratory and the Chronobiology Research Group, led by Guy Warman and James Cheeseman, at the University of Auckland's Faculty of Medical and Health Sciences.
This story was originally published on
The Conversation.
* Chris Hall
is an Associate Professor of Immunology, University of Auckland, Waipapa Taumata Rau
Sign up for Ngā Pitopito Kōrero, a daily newsletter
curated by our editors and delivered straight to your inbox every weekday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is there confusion over the role of 'physician associates'?
Is there confusion over the role of 'physician associates'?

RNZ News

timea day ago

  • RNZ News

Is there confusion over the role of 'physician associates'?

An investigation ordered by the UK government into physician associates there has found they shouldn't diagnose and treat untriaged patients. It also recommends changing their name to "assistant" rather than associate to stop them being confused with doctors. Four months ago the Health Minister, Simeon Brown, gave the go ahead for Physician Associates to become part of the regulated health workforce here. At the moment the PA's working here are trained in the UK or the US and work under the licence of a supervising doctor. The New Zealand Resident Doctors' Association has backed the two main findings of the UK report, but the New Zealand Physicians Associate Society says the situation in the UK isn't applicable here. Kathryn is joined by Deborah Powell the National Secretary of the Resident Doctors Association and Lisa deWolfe the regulation chair of the New Zealand Physician Associate Society. To embed this content on your own webpage, cut and paste the following: See terms of use.

New Barbie with type 1 diabetes could help kids with the condition feel seen - and help others learn
New Barbie with type 1 diabetes could help kids with the condition feel seen - and help others learn

RNZ News

time6 days ago

  • RNZ News

New Barbie with type 1 diabetes could help kids with the condition feel seen - and help others learn

By Lynne Chepulis and Anna Serlachius of Mattel's first Barbie with type 1 diabetes. Photo: Mattel Barbie has done many things since she first appeared in 1959 . She's been an astronaut, a doctor, a president and even a palaeontologist. Now, in 2025, Barbie is something else: a woman with type 1 diabetes . Mattel's latest Barbie was recently launched by Lila Moss , a British model who lives with type 1 diabetes. The doll comes with a visible insulin pump and a continuous glucose monitor, devices many people with diabetes rely on. To some people, this might seem like just another version of the doll. But to kids living with type 1 diabetes - especially young girls - it's a big deal. This new Barbie is not just a toy. It's about being seen. Mattel has introduced its first Barbie with Type 1 diabetes, as part of wider efforts from the toy maker to increase inclusivity among its dolls. Mattel says it partnered with Type 1 diabetes advocates to ensure that the design of the doll 'truly captures the community.' Type 1 diabetes is a condition where the body stops making insulin, the hormone that helps control blood sugar levels. It's not caused by lifestyle or diet. It's an autoimmune condition (a disorder where the immune system mistakenly attacks healthy cells) and often starts in childhood. People with type 1 diabetes need to take insulin every day, often through multiple injections or an insulin pump. They also need to check their blood sugar regularly, using finger pricks or a continuous glucose monitor worn on the skin (usually the upper arm). Although type 1 diabetes can be effectively managed, there is no cure. Millions of people across the world live with this condition, and numbers are on the rise. In Australia, type 1 diabetes affects more than 13,000 children and teens , while in New Zealand, around 2500 children under 18 have type 1 diabetes . Globally, 1.8 million young people are affected. Children with type 1 diabetes may wear a continuous glucose monitor. Photo: Pavel Danilyuk/Pexels Young people with type 1 diabetes must think about their condition every day - at school, during sports, at sleepovers and even while playing. They may have to stop what they're doing and check their blood sugar levels. It can feel isolating and frustrating. Stigma is a big issue for children and young people with type 1 diabetes . Some young people feel embarrassed using their insulin pumps or checking their blood sugar in public. One study found pre-teens with diabetes sometimes felt they received unwanted attention when using devices such as insulin pumps and glucose monitors. Stigma can make young people less likely to take care of their diabetes , which can create problems for their health. Seeing a Barbie with an insulin pump and glucose monitor could make a significant difference. Children form their sense of identity early, and toys play a surprisingly powerful role in that process. While children with type 1 diabetes can often feel different from their peers, toys can help normalise their experience and reduce the sense of isolation that can come with managing a chronic condition. Research shows toys and media such as books and TV shows reflecting children's experiences can boost self-esteem, reduce stigma and improve emotional wellbeing . For girls especially, Barbie is more than a doll. She represents what is often perceived to be admired or desirable and this can influence how girls perceive their own bodies. A Barbie with a glucose monitor and insulin pump sends a clear message: this is part of real life. You're not alone. That kind of visibility is empowering. It tells children their condition doesn't define them or limit their potential. It also helps challenge outdated stereotypes about illness and disability. Some may worry a doll with a medical condition might make playtime too serious or scary. But in reality, play is how kids learn about the world. Toys that reflect real life - including health issues - can help children process emotions, ask questions, reduce fear and feel more in control. Mattel's new Barbie shows diabetes and the devices needed to manage the condition in a positive, everyday way, and that matters. It can start conversations and help kids without diabetes learn what those devices are and why someone wears them. It builds understanding early. Mattel has added to its range of Barbies in recent years to showcase the beauty that everyone has. There are now Barbies with a wide range of skin tones, hair textures, body types and disabilities - including dolls with hearing aids , vitiligo (loss of skin pigmentation) and wheelchairs. The diabetes Barbie is part of this broader shift toward inclusivity and should be applauded. Every child should be able to find toys that reflect who they are, and the people they love. This Barbie won't make diabetes go away. But she might help a child feel more seen, more confident, more like their peers. She might help a classmate understand that a glucose monitor isn't scary - it's just something some people need. She might make a school nurse's job easier when explaining to teachers or students how to support a student with diabetes. Living with type 1 diabetes as a child is tough . Anything that helps kids feel a little more included, and a little less different, is worth celebrating. A doll might seem small. But to the right child, at the right moment, it could mean everything. * Lynne Chepulis, Associate Professor, Health Sciences, University of Waikato; Anna Serlachius, Associate Professor, Psychological Medicine, University of Auckland, Waipapa Taumata Rau - This story originally appeared on The Conversation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store